Senior Vice President - Business Development @ Vectura Group plc. (post merger with Skyepharma)
Executive Vice President - Business Development and Alliance Management @ SkyePharma AG (merged with Vectura Group in 2016)
Vice President - Corporate Development @ Vectura Group plc. (acquired Activaero in 2014)
Chief Business Officer @ Activaero (sold to Vectura Group in 2014)
Executive Director - Business Development and Alliance Mangement @ Nektar Therapeutics
Christian Pangratz's Education
Webster University
M.A. (International Business)
INSEAD
Post graduate course work - healthcare marketing and management
Stanford University
Post graduate course work with focus on biotech venture capital and business development
University of California, Berkeley
Post graduate courses for biotechnology marketing, business development and management
WU (Vienna University of Economics and Business)
Business Administration and Economics
Webster Vienna Private University
B.A. (Business Administration)
Christian Pangratz's Skills
Biotechnology
Business Development
CRO
Cross-functional Team Leadership
Diabetes
Drug Development
Medical Devices
Pharmaceutical Industry
Product Development
R
Christian Pangratz's Summary
Christian Pangratz, based in Munich, Bavaria, Germany, is currently a CEO at Atriva Therapeutics GmbH, bringing experience from previous roles at Sterna Biologicals GmbH & Co. KG, Vectura Group plc. (post merger with Skyepharma), SkyePharma AG (merged with Vectura Group in 2016) and Vectura Group plc. (acquired Activaero in 2014). Christian Pangratz holds a M.A. in International Business @ Webster University. With a robust skill set that includes Biotechnology, Business Development, CRO, Cross-functional Team Leadership, Diabetes and more, Christian Pangratz contributes valuable insights to the industry. Christian Pangratz has 5 emails on RocketReach.